MUC16 and gastric cancer: Building upon this observation, it is worth highlighting that prior research has unequivocally established the significance of TTN and MUC16 gene mutations in shaping the prognosis of gastric cancer, while also serving as pivotal biomarkers for guiding the administration of ICIs [57].